India has launched a landmark public health initiative with the rollout of the Nationwide HPV Vaccination Programme on February 28, 2026, from Ajmer, Rajasthan. This mission-mode campaign aims to eliminate cervical cancer, which remains the second most common cancer among women in the country.
By targeting adolescent girls and integrating the vaccine into the national immunization system, the government is taking a preventive, long-term approach to reduce cancer burden and improve women’s health outcomes across India. This HPV Vaccination Programme 2026 represents a significant step toward cervical cancer elimination in India.
Campaign Strategy and Eligibility
The programme has been carefully designed to ensure maximum coverage within a short period while maintaining long-term sustainability.
Primary Target Group
Approximately 1.15 crore girls aged 14 years are the main beneficiaries of the campaign.
Catch-up Provision
Girls who turn 15 within 90 days of the launch (up to late May 2026) are also eligible. This ensures that no eligible beneficiary is left out due to age cut-offs.
Implementation Timeline
The intensive campaign will run for three months, covering March, April, and May 2026. After the initial phase, the HPV vaccine India will be integrated into the National Immunization Schedule for routine administration.
This structured approach balances urgency with long-term continuity, ensuring sustained protection for future generations.
Vaccine Details and Effectiveness
The success of the programme depends heavily on the effectiveness and accessibility of the vaccines being used.
Vaccine Used in Initial Phase
The campaign primarily uses Gardasil-4, a quadrivalent vaccine. It protects against:
- HPV types 16 and 18 (responsible for most cervical cancer cases)
- HPV types 6 and 11 (linked to genital warts)
Indigenous Alternative
India is also scaling up Cervavac, developed by the Serum Institute of India. This move supports self-reliance in vaccine production and reduces dependency on imports.
Dosing Strategy
India has adopted a single-dose schedule, aligned with global recommendations. Studies show 93% to 100% effectiveness, making it both efficient and practical for large-scale rollout.
Cost to Beneficiaries
The vaccine is provided free of cost at all government health facilities, ensuring equitable access across urban and rural regions.
Registration and Digital Tracking System
To manage a campaign of this scale, the government has implemented a robust digital infrastructure.
U-WIN Platform
The U-WIN Portal serves as the central digital backbone for this nationwide HPV campaign.
Registration Options
Parents can:
- Register online via the portal
- Seek assistance from health workers
- Use on-site walk-in registration at vaccination centers
Required Documents
- Aadhaar card
- School ID
- Birth certificate
Digital Certification
After vaccination, a QR-based digital certificate is instantly generated. This ensures transparency and easy verification of vaccination status.
Safety Protocols and Operational Guidelines
Ensuring safety and public trust is a key priority in the rollout.
Consent Requirement
Vaccination is voluntary, but parental or guardian consent is mandatory. Consent records are digitally stored for accountability.
Medical Supervision
Each vaccination session is conducted under the supervision of a trained medical officer. Facilities are equipped with proper cold-chain systems to maintain vaccine quality.
Post-Vaccination Monitoring
Beneficiaries are observed for 30 minutes after vaccination. This helps detect and manage rare adverse events following immunization (AEFI).
Coverage Tracking Mechanism
A mark on the left index finger is applied, similar to electoral ink. This prevents duplication and helps track real-time coverage during the campaign.
Why This Programme Matters
Cervical cancer has long been a major public health concern in India, largely due to limited awareness, delayed diagnosis, and lack of preventive vaccination. This nationwide programme addresses the issue at its root – prevention.
Key long-term benefits include:
- Reduction in cervical cancer incidence
- Lower healthcare costs for families
- Increased awareness about women’s health
- Strengthening of India’s immunization infrastructure
By combining vaccination, digital tracking, and strong field-level execution, the programme represents one of the most comprehensive preventive healthcare initiatives in recent years.
Conclusion
The Nationwide HPV Vaccination Programme 2026 marks a turning point in India’s fight against cervical cancer. With a clear focus on adolescent health, strong government backing, and the integration of indigenous vaccines, the initiative has the potential to deliver lasting public health impact.
If successfully implemented and sustained, this programme could significantly reduce cancer-related deaths among women and set a global example for large-scale preventive healthcare strategies.
Frequently Asked Questions
Q1. What is the Nationwide HPV Vaccination Programme 2026?
A1. It is a mission-mode public health initiative launched on February 28, 2026, aimed at eliminating cervical cancer by vaccinating adolescent girls against HPV, with an intensive three-month campaign followed by routine immunization integration.
Q2. Who is eligible for the free HPV vaccine under this programme?
A2. Approximately 1.15 crore girls aged 14 years are the primary beneficiaries. Girls who turn 15 within 90 days of the launch (up to late May 2026) are also eligible under the catch-up provision.
Q3. Which vaccines are being used in the campaign?
A3. The campaign primarily uses Gardasil-4, a quadrivalent vaccine. India is also scaling up Cervavac, an indigenous vaccine developed by the Serum Institute of India.
Q4. How many doses of the HPV vaccine are required?
A4. India has adopted a single-dose schedule, aligned with global recommendations. Studies show 93% to 100% effectiveness with this approach.
Q5. How can parents register their daughters for vaccination?
A5. Parents can register through the U-WIN Portal online, seek assistance from health workers, or use on-site walk-in registration at vaccination centers. Aadhaar card, school ID, or birth certificate is required.